Produits Chimiques Auxiliaires de Synthese

Porduits Chimiques Auxiliaire et de Synthese (PCAS) and its subsidiaries produces and markets fine chemicals and specialty chemicals, offering a complete range of services. Its products include molecules and active ingredients designed to meet specific characteristics and performance criteria defined by or in partnership with customers. Co. is supported by extensive R&D capabilities and flexible and polyvalent production facilities. Co. markets its products to five global target markets: pharmaceutical synthesis and dosage forms, aroma chemicals-cosmetics, photochemistry and new technologies, industrial specialty chemicals and fine inorganic chemistry.
  • TickerPCA
  • ISINFR0000053514
  • ExchangeEuronext Paris
  • SectorChemicals
  • CountryFrance

Analysts

Pierre Vaurice

PCAS. H2 will be of better fortune

PCAS. H2 will be of better fortune

Pierre Vaurice

PCAS. RN S1 2018. Le S2 sera de meilleure fortune

PCAS. RN S1 2018. Le S2 sera de meilleure fortune

Pierre Vaurice

PCAS. A difficult start

PCAS published a turnover for Q1 of €46.4M, down by 22.8% in published data and by -20.6% at constant exchange rates.

Pierre Vaurice

PCAS. Démarrage difficile

PCAS publie un CA T1 de 46,4M€, en retrait de 22,8% en données publiées et de -20,6% à change constant.

Pierre Vaurice

PCAS. A less brillant year-end

After announcing a 2017 financial year revealing strong sales dynamics with a turnover up by 13.7%, PCAS published mixed annual results yesterday.

Pierre Vaurice

PCAS. H2 will be of better fortune

PCAS. H2 will be of better fortune

Pierre Vaurice

PCAS. RN S1 2018. Le S2 sera de meilleure fortune

PCAS. RN S1 2018. Le S2 sera de meilleure fortune

Pierre Vaurice

PCAS. A difficult start

PCAS published a turnover for Q1 of €46.4M, down by 22.8% in published data and by -20.6% at constant exchange rates.

Pierre Vaurice

PCAS. Démarrage difficile

PCAS publie un CA T1 de 46,4M€, en retrait de 22,8% en données publiées et de -20,6% à change constant.

Pierre Vaurice

PCAS. A less brillant year-end

After announcing a 2017 financial year revealing strong sales dynamics with a turnover up by 13.7%, PCAS published mixed annual results yesterday.

Ford Equity International Rating and Forecast Report

Ford Equity International Research Reports cover 60 countries with over 30,000 stocks traded on international exchanges. A proprietary quantitative system compares each company to its peers on proven measures of business value, growth characteristics, and investor behavior. Ford's three recommendation ratings buy, hold and sell, represent each stock’s return potential relative to its own country market.. The rating reports which are generated each week, include the fundamental details behind each recommendation and reflect the fundamental and price data as of the last trading day of the week...

Etude de l'AG du 28/06/2017

Deux résolutions soumettent au vote des actionnaires les politiques de rémunération du Directeur Général et du Président du conseil pour 2017 (articles L225-37-2 et L225-82-2 du Code de commerce créés pas la loi n°2016-1691 du 9 décembre 2016 dite Loi « Sapin 2 »). Cependant, la société ne fournit aucune information concernant la politique de rémunération pour 2017. Il semblerait que la société fasse une confusion entre la résolution issue de la loi Sapin II qui soumet au vote la politique de rémunération pour 2017 et la résolution Say on Pay du code Afep-Medef qui soumet au vote les rémunérat...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch